TFX logo

Teleflex Incorporated Stock Price

NYSE:TFX Community·US$5.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

TFX Share Price Performance

US$127.71
-105.25 (-45.18%)
16.4% undervalued intrinsic discount
US$152.80
Fair Value
US$127.71
-105.25 (-45.18%)
36.1% undervalued intrinsic discount
US$200.00
Fair Value
Price US$127.71
AnalystHighTarget US$200.00
AnalystConsensusTarget US$132.63
AnalystLowTarget US$120.00

TFX Community Narratives

AnalystHighTarget·
Fair Value US$152.8 16.4% undervalued intrinsic discount

Aging Populations And Emerging Markets Will Transform Medical Devices

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$132.63 3.7% undervalued intrinsic discount

Acquisitions And Asian Expansion Will Broaden Healthcare Horizons

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystLowTarget·
Fair Value US$120 6.4% overvalued intrinsic discount

Rising Cost Pressures And Supply Risks Will Shrink Healthcare Prospects

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent TFX News & Updates

Teleflex In 2025: A Company Trying To Reset

Sep 14

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Results: Teleflex Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 04
Results: Teleflex Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates

Teleflex (NYSE:TFX) Has Announced A Dividend Of $0.34

Aug 03
Teleflex (NYSE:TFX) Has Announced A Dividend Of $0.34

Teleflex Incorporated (NYSE:TFX) Not Lagging Market On Growth Or Pricing

Jul 10
Teleflex Incorporated (NYSE:TFX) Not Lagging Market On Growth Or Pricing

Teleflex Incorporated Key Details

US$3.0b

Revenue

US$1.3b

Cost of Revenue

US$1.7b

Gross Profit

US$1.5b

Other Expenses

US$191.9m

Earnings

Last Reported Earnings
Jun 29, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.34
Gross Margin
55.89%
Net Profit Margin
6.31%
Debt/Equity Ratio
47.3%

Teleflex Incorporated Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with adequate balance sheet.

2 Risks
3 Rewards

About TFX

Founded
1943
Employees
14100
CEO
Liam Kelly
WebsiteView website
www.teleflex.com

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.1%
  • 3 Months: 8.9%
  • 1 Year: 18.9%
  • Year to Date: 15.1%
Over the last 7 days, the market has risen 1.1%, driven by gains of 1.9% in the Information Technology sector. As for the past 12 months, the market is up 19%. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›